Navigating An Ever-Changing Landscape: The Role Of A CFO In A Private Equity Controlled Pharma Company

By Kurt R. Nielsen, Ph.D., President and CEO, Pharmaceutics International, Inc (Pii)


The role of Chief Financial Officer for a small-to-mid size pharma company controlled by private equity is a challenging one. It requires balancing the competing demands of the Board of Directors, other executives, staff, and investors or shareholders.

However, most small-to-mid-size pharma companies with limited internal resources rely on CDMOs for support and they can be a great help to CFOs.

Kurt Nielsen, CEO of Pharmaceutics International shares his thoughts on how CFOs of pharma companies controlled by private equity can use their CDMOs to be more successful.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma

Pharmaceutics International